AbbVie 8-K

Shareholder vote

Proposal to eliminate supermajority voting failed despite 98.9% of votes cast in favor.

Filed 2026-05-12 17:01 ET

Summary

2026 annual meeting vote results. Stockholders did not approve management’s proposal to eliminate supermajority voting, despite 98.9% of votes cast being in favor. The directors were elected, the auditor was ratified, executive compensation was approved, and the independent-chair proposal was rejected.

Key Figures

  • Supermajority-voting amendment: 1.291B votes for, 14.9M against and 3.19M abstentions; 98.9% of votes cast were for.
  • Jennifer L. Davis: 1.217B for, 89.8M against. Melody B. Meyer: 1.285B for, 22.5M against. Robert A. Michael: 1.221B for, 85.9M against. Frederick H. Waddell: 1.225B for, 81.7M against.
  • Independent-chair proposal: 515.6M for and 787.3M against. Executive compensation received 1.229B votes for and 69.3M against; Ernst & Young’s 2026 appointment received 1.523B for and 23.8M against.

Guidance

No guidance in this filing.

The summary is written by an AI model reading the filing.

Model 005 · prompt 01d34d48e3

Feedback